CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 143 enrolled
Drug / intervention
PRISM (Promoting Resilience in Stress Management)behavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03640325
NCT03640325N/ACompleted
CompareCT.gov

The Promoting Resilience in Stress Management (PRISM) Intervention: a Multi-site Randomized Controlled Trial for Adolescents and Young Adults Receiving Hematopoietic Cell Transplantation

Seattle Children's Hospital·interventional·Posted Aug 21, 2018·Updated Oct 26, 2024

In Brief

A clinical study evaluating PRISM (Promoting Resilience in Stress Management) for Cancer and 7 related conditions. Completed, enrolled 143 participants across 5 sites.

Detailed Summary

Multisite Randomized Controlled Trial (RCT) testing the efficacy of the Promoting Resilience in Stress Management (PRISM) intervention among Adolescents and Young Adults receiving hematopoietic cell transplantation for hematology malignancy.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCancer, Bone Marrow Neoplasms, Anxiety, Depression, Quality of Life, Adherence, Medication, Coping Skills, Adolescent Behavior
CountriesUnited States
CollaboratorsChildren's Hospital Los Angeles, St. Jude Children's Research Hospital, University of Alabama at Birmingham, National Cancer Institute (NCI)

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedAug 21, 2018
Enrollment StartApr 1, 2019
Primary CompletionMar 31, 2023
Study CompletionMar 31, 2024
TodayJul 2, 2026
Enrollment to primary: 4 yearsPosted 7.9 years ago

Interventions

PRISM (Promoting Resilience in Stress Management)behavioral

Manualized Skills-Training Program targeting resilience resources: stress-management, goal-setting, cognitive reframing, and meaning-making